Introduction
The Stem Cell & Regenerative Medicine institute was launched to develop novel medical technologies to restore impaired tissues or organs damaged due to aging, diseases or accidents. The institute has mainly focused on translational researches and the development of novel medical therapeutics for incurable and refractory diseases.
The main target diseases and research fields are musculoskeletal and joint diseases, stroke, dementia and degenerative brain disease, incurable diseases of preterm infants, hematopoietic stem cell transplantation, peripheral nerve disorders, hepatocyte regeneration, blood vessel disease, intractable diabetes, kidney disease, spinal cord damage, brain tumor, transplantation immunity, and hair loss and skin regeneration.
Contact
E-mail : scrmc.smc@samsung.com